Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia

Bone Marrow Transplantation

Volumn 18, Issue 5, 1996, Pages 907-911

  Copelan, E A ^a,b   Penza, S L ^a   Elder, P J ^a   Belt, P S ^a   Scholl, M D ^a   Hehmeyer, D M ^a   Ezzone, S A ^a   Bechtel, T P ^a   Avalos, B R ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Allogeneic transplantation; Graft versus host disease; Leukemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE; STEROID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SIBLING; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BUSULFAN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; TREATMENT OUTCOME;

EID: 0029854124     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Weiden PL, Flournoy N, Thomas ED et al. Antileukemia effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
2. Weiden PL, Sullivan KN, Flournoy N et al. Antileukemic effect of chronic graft-vs-host disease: contributions to improved survival after allogeneic marrow transplantation. New Engl J Med 1981; 304: 1529-1533.
3. Weisdorf DJ, Nesbit ME, Ramsay NKC et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-vs-host disease. J Clin Oncol 1987; 5: 1348-1355.
4. Butturini A, Bortin MM, Gale RP. Graft-vs-leukemia following bone marrow transplantation. Bone Marrow Transplant 1987; 2: 233-242.
5. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
6. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
7. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of acute graft-vs-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
8. Working Party on Leukemia, European Group for Bone Marrow Transplantation. Allogeneic bone marrow transplantation for leukaemia in Europe. Lancet 1988; 1: 1379-1382.
9. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Engl J Med 1983; 309: 1347-1353.
10. Biggs JC, Szer J, Crilly P et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1992; 80: 1352-1357.
11. Blume KG, Kopecky KJ, Henslee-Downey JP et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993; 81: 2187-2193.
12. Ringdén O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplant Group. Blood 1994; 83: 2723-2730.
13. Vaughan WP, Dennison JD, Reed EC et al. Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy. Bone Marrow Transplant 1991; 8: 489-495.
14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
15. Shulman HM, Sale GE, Lerner KG et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978; 91: 545-570.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
17. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34: 187-202.
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
19. Copelan EA. Conditioning regimens for allogeneic bone marrow transplantation. Blood Rev 1992; 6: 234-242.
20. Copelan EA, Biggs JC, Avalos BR et al. Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 237-242.
21. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
22. Kernan NA, Collins NH, Juliano L et al. Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft versus host disease. Blood 1986; 68: 770-773.
23. Mackinnon S, Papadopoulos EB, Carabasi MH. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
24. Elfenbein GJ, Graham-Pole J, Weiner RS et al. No prophylaxis for acute graft versus host disease. Progress in Bone Marrow Transplantation: Proceedings of the Fourth International UCLA Symposium on Bone Marrow Transplantation. Keystone, CO, 13-18 April, 1986, Alan R Liss: New York, 1987, pp 295-306.
25. Sullivan KM, Deeg HJ, Sanders J et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986; 67: 1172-1175.
26. Sullivan KM, Storb R, Buckner CD et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. New Engl J Med 1989; 320: 828-834.